Responsiveness and Minimal Important Change of Two Measures of Pain Intensity in People With Low Back Pain

This is an observational study aimed at evaluating the responsiveness and minimal important change of two measures of pain intensity in people with low back pain. It consists of a battery of self-administered questionnaires which will be given to individuals with low back pain to complete before and after a rehabilitation treatment. Relationships among the different outcome measures will be also evaluated.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This is an observational study aimed at evaluating the responsiveness and minimal important change of two different graphical ways to assess pain intensity in people with low back pain.

Literature found out that low back pain intensity is commonly assessed by a numerical rating scale ranging from no pain to the worst imaginable pain, once presented to responders horizontally. A different way to assess pain intensity could be to answer a similar numerical rating scale if set vertically.

In Literature there are not studies which head-to-head evaluate the responsiveness and minimal important change of these two ways of assessing pain intensity due to low back pain.

Participants will also have to complete self-reported outcome measures of disability, catastrophizing, fear of movement and self-efficacy, and correlations among these tools and the above two different ways to evaluate pain intensity will be evaluated. Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample under investigation.

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Non-specific low back pain is defined as low back pain not attributable to a recognizable, known specific pathology (eg, infection, tumour, osteoporosis, lumbar spine fracture, structural deformity, inflammatory disorder,radicular syndrome, or cauda equina syndrome).

Description

Inclusion Criteria:

  • Non specific low back pain
  • Adult age
  • Ability to understand the Italian language

Exclusion Criteria:

  • Refuse to adhere to the study
  • Definite causes of low back pain
  • Central or peripheral neurological signs
  • Systemic illness or psychiatric deficits
  • Recent myocardial infarction, cerebrovascular events, or chronic lung or renal diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Numerical Rating Scale; score 0-10 with higher estimates indicating higher levels of pain intensity (horizontal line)
Immediately before the rehab treatment starts and immediately after the intervention
Gauge of pain
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Numerical Rating Scale; score -5/+5 with lower estimates indicating higher levels of pain intensity (vertical line)
Immediately before the rehab treatment starts and immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ODI
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Oswestry Disability Index; score 0-50 with higher scores representing greater restriction to activities.
Immediately before the rehab treatment starts and immediately after the intervention
PCS
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Pain Catastrophizing Scale; score 0-52 with higher estimates showing higher catastrophizing
Immediately before the rehab treatment starts and immediately after the intervention
TSK
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Tampa Scale of Kinesiophobia; score 13-52 with higher estimates showing higher fear of movement
Immediately before the rehab treatment starts and immediately after the intervention
PSEQ
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
Pain Self Efficacy Questionnaire; score 0-60 with higher estimates showing higher self-effficacy
Immediately before the rehab treatment starts and immediately after the intervention
GPE
Time Frame: Immediately after the intervention
Global Perceived Effect (how much did the treatment received help your pain?); score -3 (it worsen a lot the things)/+3 (it helped a lot)
Immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

February 28, 2025

Study Registration Dates

First Submitted

February 5, 2024

First Submitted That Met QC Criteria

February 13, 2024

First Posted (Estimated)

February 21, 2024

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 13, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Excercise-based therapy

3
Subscribe